MLchartDataset catalogue

allogeneic AML antigen-expressing dendritic cell vaccine

Term · Oncology and biomedicine · MLC-T-ONC-009792

A cancer vaccine consisting of allogeneic, immortalized dendritic precursor cells derived from a patient with acute myelogenous leukemia (AML), with potential immunostimulatory and antineoplastic activities. Upon ex vivo stimulation and expansion of the precursor cells into mature, fully functional dendritic cells (DCs) and subsequent administration, the allogeneic AML antigen-expressing DC vaccine may elicit a potent cytotoxic T-cell (CTL) and antibody response against AML antigen-expressing cells, resulting in tumor cell death.

Table 1. Record
IdentifierMLC-T-ONC-009792
FieldOncology and biomedicine
Synonymsallogeneic acute myeloid leukemia antigen-expressing dendritic cell vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009792",
  "term": "allogeneic AML antigen-expressing dendritic cell vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of allogeneic, immortalized dendritic precursor cells derived from a patient with acute myelogenous leukemia (AML), with potential immunostimulatory and antineoplastic activities. Upon ex vivo stimulation and expansion of the precursor cells into mature, fully functional dendritic cells (DCs) and subsequent administration, the allogeneic AML antigen-expressing DC vaccine may elicit a potent cytotoxic T-cell (CTL) and antibody response against AML antigen-expressing cells, resulting in tumor cell death.",
  "synonyms": [
    "allogeneic acute myeloid leukemia antigen-expressing dendritic cell vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-aml-antigen-expressing-dendritic-cell-vaccine/"
}

Record 677 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.